PT - JOURNAL ARTICLE AU - Samuel Altmann AU - Luke Milsom AU - Hannah Zillessen AU - Raffaele Blasone AU - Frederic Gerdon AU - Ruben Bach AU - Frauke Kreuter AU - Daniele Nosenzo AU - Séverine Toussaert AU - Johannes Abeler TI - Acceptability of app-based contact tracing for COVID-19: Cross-country survey evidence AID - 10.1101/2020.05.05.20091587 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.05.20091587 4099 - http://medrxiv.org/content/early/2020/05/08/2020.05.05.20091587.short 4100 - http://medrxiv.org/content/early/2020/05/08/2020.05.05.20091587.full AB - Background The COVID-19 pandemic is the greatest public health crisis of the last 100 years. Countries have responded with various levels of lockdown to save lives and stop health systems from being overwhelmed. At the same time, lockdowns entail large socio-economic costs. One exit strategy under consideration is a mobile phone app that traces close contacts of those infected with COVID-19. Recent research has demonstrated the theoretical effectiveness of this solution in different disease settings. However, concerns have been raised about such apps because of the potential privacy implications. This could limit the acceptability of app-based contact tracing among the general population. As the effectiveness of this approach increases strongly with app take-up, it is crucial to understand public support for this intervention.Objectives The objective of this study is to investigate user acceptability of a contact-tracing app in five countries hit by the pandemic.Methods We conducted a multi-country, large-scale (N = 5995) study to measure public support for digital contact tracing of COVID-19 infections. We ran anonymous online surveys in France, Germany, Italy, the UK and the US. We measured intentions to use a contact-tracing app across different installation regimes (voluntary installation vs. automatic installation by mobile phone providers), and studied how these intentions vary across individuals and countries.Results We found strong support for the app under both regimes, in all countries, across all sub-groups of the population, and irrespective of regional-level COVID-19 mortality rates. We investigated the main factors that may hinder or facilitate take-up and found that concerns about cyber security and privacy, together with lack of trust in government, are the main barriers to adoption.Conclusions Epidemiological evidence shows that app-based contact-tracing can suppress the spread of COVID-19 if a high enough proportion of the population uses the app and that it can still reduce the number of infections if take-up is moderate. Our findings show that the willingness to install the app is very high. The available evidence suggests that app-based contact tracing may be a viable approach to control the diffusion of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge funding from the Economic and Social Research Council (grant ES/R011710/1), the University of Oxford and Volkswagen Foundation (grant ‘Consequences of Artificial Intelligence for Urban Societies’).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available at https://osf.io/7vgq9/ under a CC-BY license. https://osf.io/7vgq9/